See All Slides - tctmd.com

Slides

Presentation TCT 2013

Use of Tandem Heart as Bridge to Recovery or Transplantation

Presenter: Graham Cassel

October 28, 2013

Presentation TCT 2013

In the Absence of Any Other Good ideas, This Is the Best Strategy!

Presenter: Lisa Jennings

October 28, 2013

Presentation TCT 2013

Who Should Be Operated on for Functional MR? Guidelines and Practice (Heart Failure Specialist Perspectives)

Presenter: JoAnn Lindenfeld

October 28, 2013

Presentation TCT 2013

DES in Complex Lesions: The Plague of Calcified Plaque

Presenter: Philippe Généreux

October 28, 2013

Presentation TCT 2013

Trans-ureteral Renal Sympathetic Denervation (Verve Medical)

Presenter: Richard Heuser

October 28, 2013

Presentation TCT 2013

TVA-FLEX: Safety and Efficacy of Percutaneous Autogenous Arteriovenous Fistula Creation

Presenter: William Cohn

October 28, 2013

Presentation TCT 2013

The Hybrid Approach I: The Algorithm and the Registry

Presenter: David Daniels

October 28, 2013

Presentation TCT 2013

New FDA Innovation Pathways: Returning Early Stage Device Development to the United States

Presenter: Andrew Farb

October 28, 2013

Presentation TCT 2013

TCT-136. Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved or Mildly Reduced Ejection Fraction

Presenter: Finn Gustafsson

October 28, 2013

Presentation TCT 2013

Monitoring Graft Adequacy and Possible Causes of Graft Failure

Presenter: Alex Powell

October 28, 2013

Advertisement

Slides

Use of Tandem Heart as Bridge to Recovery or Transplantation

In the Absence of Any Other Good ideas, This Is the Best Strategy!

Who Should Be Operated on for Functional MR? Guidelines and Practice (Heart Failure Specialist Perspectives)

DES in Complex Lesions: The Plague of Calcified Plaque

Trans-ureteral Renal Sympathetic Denervation (Verve Medical)

TVA-FLEX: Safety and Efficacy of Percutaneous Autogenous Arteriovenous Fistula Creation

The Hybrid Approach I: The Algorithm and the Registry

New FDA Innovation Pathways: Returning Early Stage Device Development to the United States

TCT-136. Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved or Mildly Reduced Ejection Fraction

Monitoring Graft Adequacy and Possible Causes of Graft Failure

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content